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In the published article \[[@CR1]\], an error was noticed in Fig. [6](#Fig1){ref-type="fig"}b. The western blot results were reversed between the overexpression group and the knockdown group of circ-AKT3. The corrected and updated Fig. [6](#Fig1){ref-type="fig"} is provided below. This error does not affect the findings or conclusions of the article. Fig. 6AKT3-174aa competitively interacts with p-PDK1 form ATK2/3. **a** PDK1 kinase activity was determined in U251 and U373 cells with circ-AKT3 overexpression and their control cells at the indicated time point. Error bars represent three independent experiments, \*\*, *p* \< 0.01. **b** Upper, AKT kinase activity was determined in U251 and U373 cells with circ-AKT3 overexpression and their control cells (48 h); or in SW1783 and Hs683 cells with circ-AKT3 knocking down and their control cells (48 h). Error bars represent three independent experiments, \*, *p* \< 0.05, \*\*, *p* \< 0.01. Lower, p-SGK level was determined in indicated cells. **c** U251 cells were transfected with increasingly dose of circ-AKT3. IP was performed by using AKT2, AKT3 and p-PDK1 antibodies and followed by immunoblot using indicated antibodies. **d** SW1783 cells were transfected with increasingly dose of circ-AKT3 shRNA. IP was performed by using AKT2, AKT3 and p-PDK1 antibodies and followed by immunoblot using indicated antibodies
